Metformin lowers risk of long Covid Study

Minneapolis [US], June 9 (ANI): University of Minnesota researchers discovered that metformin, a medicine typically used to treat diabetes, reduces the development of protracted Covid in a recent study published in The Lancet Infectious Diseases. The study, called Covid-OUT, investigated if early outpatient Covid-19 treatment with metformin, ivermectin or fluvoxamine…Read More